ProPhase Labs Urges Shareholders to Vote by November 23 on Proxy Proposals

Core Viewpoint - ProPhase Labs, Inc. is urging shareholders to vote in favor of all proposals at the upcoming Special Meeting to support the company's long-term strategic vision and compliance with Nasdaq listing requirements [3][4]. Group 1: Special Meeting Details - The Special Meeting of Stockholders is scheduled for November 24, 2025, at 10:00 a.m. ET, for shareholders of record as of October 20, 2025 [1]. - Shareholders are encouraged to vote their shares before the proxy voting deadline of 11:59 p.m. ET on November 23, 2025 [2]. Group 2: Importance of Voting - Voting FOR all proposals will enable ProPhase Labs to advance its strategic initiatives and maintain compliance with Nasdaq requirements [3]. - Not voting is equivalent to voting against the proposals, which could limit the company's strategic options and hinder its ability to capitalize on new opportunities [4]. Group 3: Company Overview - ProPhase Labs, Inc. is a biotech and consumer products company focused on innovative healthcare solutions, including Whole Genome Sequencing and diagnostic tests [6]. - The company aims to build a healthier world through innovation and actionable insights, with a commitment to executional excellence and smart diversification [6].